In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

2024 . Beksac, Meral | Eikema, Diderik-Jan | Koster, Linda | Hulin, Cyrille | Poiré, Xavier | Hamladji, Rose-Marie | Gromek, Tomasz | Bazarbachi, Ali | Ozkurt, Zubeyde Nur | Pabst, Thomas | Ben Othman, Tarek | Finke, Juergen | Pirogova, Olga | Wu, Depei | Hayat, Amjad | Hilgendorf, Inken | Tholouli, Eleni | de Wreede, Liesbeth | Schönland, Stefan | Garderet, Laurent | Drozd-Sokolowska, Joanna | Raj, Kavita | Hayden, Patrick | Yakoub-Agha, Ibrahim | McLornan, Donal